Ryan Morin

Integrated multiomic profiling reveals 2 distinct splenic marginal zone lymphoma subgroups with prognostic relevance.

Parker H, Mirandari A, Stevens B, Oquendo CJ, Duran-Ferrer M, Buermann L, Amarasinghe HE, Thomas J, Carr L, Syeda S, Sakthipakan M, Parry M, Rose-Zerilli MJJ, Davis Z, McIver-Brown N, Xochelli A, Ennis S, Scarfò L, Ghia P, Kalpadakis C, Pangalis G, Rossi D, Gaidano G, Wagner S, Ahearne M, Seifert M, Plass C, Weichenhan D, Kimby E, Sutton LA, Rosenquist R, Amini RM, Ljungström V, Pratt G, Forconi F, Stamatopoulos K, Salido M, Ferrer A, Thieblemont C, Hilton L, Morin R, Walewska R, Martín-Subero JI, Oscier D, Oakes C, Gibson J, Bryant D, Strefford JC

Regulatory factor X 7 limits Myc activity during B cell activation and suppresses Myc-dependent lymphomagenesis.

Fischer BA, Khameneh HJ, Guerra J, Zenobi A, Ciorciari J, Buzzago I, Merli MS, Said M, Ventura PMO, Pfister A, Mattei L, Cavalli D, Molinari F, Rinaldi A, Moro SG, Kwee I, Morone D, Mosole S, Jarrossay D, Montanino C, Simonelli L, Varani L, Radice E, Thelen M, Di Serio C, Calabretta E, Shipp MA, Dreval K, Morin R, Scott DW, Jauk F, Frattini M, Barizzi J, Cascione L, Bertoni F, Robbiani DF, Rossi D, Guarda G

Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma.

Sharma S, Ali R, Bouska A, Jochum D, Kesireddy M, Mahov S, Lownik J, Zhang W, Lone W, Soma MA, Gamboa A, Devarakonda V, El-Gamal D, Fariha A, Mansoor A, Stewart D, Martin P, Link BK, Advani RH, Barr PM, Goy AH, Mehta A, Kamdar M, Stephens DM, Bachanova V, Smith L, Morin R, Pararajalingam P, Lunning MA, Fu K, Weisenburger D, Chan WC, Khoury J, Greiner TC, Vose JM, Merchant A, Bi C, Iqbal J, North American Mantle Cell Lymphoma Project (NAMCLP)

Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma.

Sircar A, Singh S, Xu-Monette ZY, Coyle KM, Hilton LK, Chavdoula E, Ranganathan P, Jain N, Hanel W, Tsichlis P, Alinari L, Peterson BR, Tao J, Muthusamy N, Baiocchi R, Epperla N, Young KH, Morin R, Sehgal L

Molecular attributes underlying central nervous system and systemic relapse in diffuse large B-cell lymphoma.

Isaev K, Ennishi D, Hilton L, Skinnider B, Mungall KL, Mungall AJ, Bakhtiari M, Tremblay-LeMay R, Silva A, Ben-Neriah S, Boyle M, Villa D, Marra MA, Steidl C, Gascoyne RD, Morin R, Savage KJ, Scott DW, Kridel R

Indigenous sex-selective salmon harvesting demonstrates pre-contact marine resource management in Burrard Inlet, British Columbia, Canada

Collaborative intra-tumor heterogeneity detection.

Khakabimamaghani S, Malikic S, Tang J, Ding D, Morin R, Chindelevitch L, Ester M

Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi.

Zaja F, Salvi F, Rossi M, Sabattini E, Evangelista A, Ciccone G, Angelucci E, Gaidano G, Zanni M, Ladetto M, Chiappella A, Vitolo U, Zinzani PL, Califano C, Tucci A, Patti C, Pileri SA, Lenti V, Piccaluga PP, Cavallo F, Volpetti S, Perali G, Assouline S, Mann KK, Morin R, Alcaide M, Bushell K, Fanin R, Levis A

Targeted Error-Suppressed Detection of Circulating Paternal DNA to Establish a Diagnosis of Gestational Trophoblastic Neoplasm.

Lavoie JM, Alcaide M, Fisher RA, Seckl MJ, Morin R, Tinker AV

Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations.

Louissaint A, Schafernak KT, Geyer JT, Kovach AE, Ghandi M, Gratzinger D, Roth CG, Paxton CN, Kim S, Namgyal C, Morin R, Morgan EA, Neuberg DS, South ST, Harris MH, Hasserjian RP, Hochberg EP, Garraway LA, Harris NL, Weinstock DM